Table 2 Details of patient reported imaging
A: Summary of patient reported perioperative imaging for distant metastases | ||||
Patients reporting at least one imaging test for metastatic disease (%) | 198 (80.8%) | |||
Reported imaging by site (% of total patients): | ||||
Thorax | 177 (72.2%) | |||
Abdomen | 137 (55.9%) | |||
Skeleton | 160 (65.3%) | |||
Total imaging tests by site (% of total imaging): | ||||
Thorax | 300 (42.8%) | |||
Abdomen | 213 (30.4%) | |||
Skeleton | 188 (26.8%) | |||
Total imaging tests (# per patient imaged) | 701 (3.5) | |||
B: Imaging details | ||||
Stage 1 (n = 88) | Stage 2 (n = 69) | Stage 3 (n = 40) | Unknown Stage (n = 48) | |
Thoracic imaging: | ||||
Reported in (%) | 52 (59.1%) | 55 (79.7%) | 32 (80.0%) | 38 (79.2%) |
Total # of imaging tests of chest (% of total of 300) | 82 (27.3%) | 91 (30.3%) | 59 (19.7%) | 68 (22.7%) |
Imaging details: | ||||
CXR only (%) | 25 (28.4%) | 29 (42.0%) | 11 (27.5%) | 15 (31.3%) |
CT-chest only (%) | 9 (10.2%) | 4 (5.8%) | 3 (7.5%) | 3 (6.3%) |
CXR + CT-chest (%) | 18 (20.5%) | 22 (31.9%) | 18 (45.0%) | 20 (41.7%) |
Abdominal imaging: | ||||
Reported in (%) | 38 (43.2%) | 44 (63.8%) | 29 (72.5%) | 26 (54.2%) |
Total imaging tests of abdomen (% of total of 213) | 61 (28.6%) | 60 (28.2%) | 51 (23.9%) | 41 (19.2%) |
Imaging details: | ||||
US only (%) | 23 (26.1%) | 28 (40.6%) | 11 (27.5%) | 12 (25.0%) |
CT only (%) | 1 (1.1%) | 7 (10.1%) | 4 (10%) | 4 (8.3%) |
MRI only (%) | 1 (1.1%) | 1 (1.4%) | 1 (2.5%) | 0 (0%) |
Two or more of US/CT/MRI (%) | 13 (14.8%) | 8 (11.6%) | 13 (32.5%) | 10 (20.8%) |
Skeletal imaging: (all reported isotope bone scan) | ||||
Reported in (%) | 45 (51.1%) | 49 (71.0%) | 35 (87.5%) | 31 (64.6%) |